June 17-19, 2013
The Revere Hotel, 200 Stuart St., Boston, MA 02116
This established and well recognized kinase conference addresses re-occurring questions about selectivity, safety, resistance and novelty. After many years of research and therapeutic developments of kinase inhibitors, the field still offers new opportunities as novel kinases and their inhibitors are making an appearance. In addition, interest in the repurposing of already developed drugs is growing immensely.
This conference addresses questions such as what lies ahead, what is in store for the pharmaceutical industry and what new avenues are opening up in regards to technologies and methods used or in regards to novel targets and therapeutic approaches explored. Take advantage of the opportunity to present your data, concepts and results as part of a highly knowledgeable speaker faculty by submitting a speaking proposal for this event.